FDG-PET is a nuclear medicine procedure that can used to show images of sugar metabolism. . 

Indications:

• Oncology:

• • Localization of a tumor
  • Assessment of malignancy
  • Assessment of the spread (metastases?) and the stage of the disease
  • Checking the success of treatment after surgery, radiotherapy, and/or chemotherapy

• Neurology:
  • Differentiation of dementia-related diseases (e.g. Alzheimer's disease, vascular dementia)
  • Clarification of epileptic seizures
• Infectology:
  • Infect focus search
• Cardiology:
  • Assessment of myocardial vitality
  • Assessment of sarcoidosis

Preparation for the examination: fasting is required (calorie-free drinks such as mineral water permitted)

Procedure of the examination:

• Doctor's consultation to explain any uncertainties regarding the examination
• Determination of the blood glucose level (<8.3 mmol/l)
• Injection of the radiopharmaceutical (possibly administration of furosemide)
• Quiet positioning for 60 minutes
• Preparation of the images
• The findings are sent to the requesting doctor in writing as soon as possible.

Radiopharmaceutical used::

• F-18-FDG (Zuckerderivat)

Exemplary case studies on FDG-PET/CT diagnostics:

Case study of dementia: 

Case study Oncology: